Gelonghui May 10 δΈ¨ Shuiyang Shares (300740vegasslots.SZ) said on the investor interaction platformvegasslotsIn the field of synthetic biology, the company earlier cooperated with the team of Academician Chen Jian of Jiangnan University and hired Academician Chen Jian as the chief scientist in 2022, and has obtained 11 patented technologies; among them, Jiangnan University has transferred 6 patents related to the use of synthetic biology for the production of small molecules hyaluronic acid, independently researched and developed 5 patents on raw material preparation, testing and application, and applied the relevant technologies in Yumifang Micro 800, Micro 400 Hyaluronic Acid Secondary Essence and other products. In addition, the tetrahydropyrimidine (ecdoin) strain developed in cooperation with Jiangnan University can be mass-produced.

vegasslots| Shuiyang Co., Ltd.(300740.SZ): The tetrahydropyrimidine (ecdoin) strain developed in cooperation with Jiangnan University has been mass-produced